Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID-19 VACCINE”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT04885907
What this trial is testing

Third Dose of Moderna COVID-19 Vaccine in Transplant Recipients

Who this might be right for
Vaccine Response ImpairedImmune SuppressionCovid19
University Health Network, Toronto 120
Very early researchUnknownNCT05585567
What this trial is testing

A Preliminary Exploratory Study to Evaluate the Safety and Immunogenicity of Omicron Variant Bivalent Vaccine V-01-B5

Who this might be right for
COVID-19 Pandemic
Livzon Pharmaceutical Group Inc. 48
Early research (Phase 1)Study completedNCT06851611
What this trial is testing

The Safety and Antibody Response of the Nasal COV2 Vaccine Against the SARS-CoV-2 Virus

Who this might be right for
COVID19, Sars-Cov-2
Rokote Laboratories Finland Oy 40
Large-scale testing (Phase 3)UnknownNCT05664932
What this trial is testing

Immunogenicity and Safety of COVID-19 Vaccine as a Booster Vaccination in Population Aged 18 Years and Above

Who this might be right for
COVID-19
Guangzhou Patronus Biotech Co., Ltd. 1,200
Early research (Phase 1)Study completedNCT04619628
What this trial is testing

Safety and Immunogenicity of COVI-VAC, a Live Attenuated Vaccine Against COVID-19

Who this might be right for
COVID-19
Codagenix, Inc 48
Large-scale testing (Phase 3)Ended earlyNCT04904549
What this trial is testing

Study of Monovalent and Bivalent Recombinant Protein Vaccines Against COVID-19 in Adults 18 Years of Age and Older

Who this might be right for
COVID-19
Sanofi Pasteur, a Sanofi Company 23,670
Not applicableStudy completedNCT04751734
What this trial is testing

Impact of Maternal COVID-19 Vaccines on Breast Milk

Who this might be right for
COVID-19 Vaccines
Institute of Agrochemistry and Food Technology, National Research Council 120
Post-approval studies (Phase 4)UnknownNCT05373030
What this trial is testing

Sequential Immunization With Recombinant Adenovirus Type-5-vectored COVID-19 Vaccine in Health Adults Based on 3 Doses Inactivated COVID-19 Vaccine

Who this might be right for
Immunogenicity and Safety of a Recombinant Adenovirus Type-5-vectored COVID-19 Vaccine Using for Sequential Immunization
Zhejiang Provincial Center for Disease Control and Prevention 200
Post-approval studies (Phase 4)Study completedNCT04911790
What this trial is testing

Safety of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Adults

Who this might be right for
COVID-19
Sinovac Research and Development Co., Ltd. 131,650
Not applicableEnrolling By InvitationNCT05610423
What this trial is testing

Covid-19 Vaccine Associated Myocarditis and Pericarditis in Norway

Who this might be right for
Myocarditis
Oslo University Hospital 100
Testing effectiveness (Phase 2)UnknownNCT05087368
What this trial is testing

Immunogenicity and Safety of Heterologous and Homologous Boosting With ChAdOx1-S and CoronaVac or a Formulation of SCB-2019 (COVID-19)

Who this might be right for
Covid19
D'Or Institute for Research and Education 520
Early research (Phase 1)Study completedNCT05477186
What this trial is testing

Safety and Immunogenicity Study of a Booster Dose of the Investigational CV0501 mRNA COVID-19 Vaccine in Adults at Least 18 Years Old

Who this might be right for
COVID-19SARS-CoV-2
GlaxoSmithKline 185
Not applicableStudy completedNCT05729191
What this trial is testing

Evaluation of the Acceptance of the Anti-COVID-19 Vaccine Offer Among Pregnant Women

Who this might be right for
Pregnant WomenCOVID 19 VaccineVaccination Hesitancy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 100
Early research (Phase 1)UnknownNCT05396573
What this trial is testing

A Phase 1b Trial to Evaluate the Safety and Immunogenicity of a SARS-CoV-2 mRNA Chimera Vaccine Against COVID-19

Who this might be right for
COVID-19
Walvax Biotechnology Co., Ltd. 120
Large-scale testing (Phase 3)Active Not RecruitingNCT05556720
What this trial is testing

Bringing Optimised COVID-19 Vaccine Schedules To ImmunoCompromised Populations (BOOST-IC): an Adaptive Randomised Controlled Clinical Trial

Who this might be right for
HIVOrgan TransplantationLymphoma, Non-Hodgkin+3 more
Monash University 960
Large-scale testing (Phase 3)WithdrawnNCT04990466
What this trial is testing

Phase 2b/3 Trial of VSV-ΔG SARS-CoV-2 Vaccine (BRILIFE) Against Approved Comparator Vaccine.

Who this might be right for
COVID-19
NeuroRx, Inc.
Post-approval studies (Phase 4)Study completedNCT04892459
What this trial is testing

Study on Sequential Immunization of Inactivated SARS-CoV-2 Vaccine and Recombinant SARS-CoV-2 Vaccine (Ad5 Vector)

Who this might be right for
COVID-19
Jiangsu Province Centers for Disease Control and Prevention 300
Early research (Phase 1)Study completedNCT04816019
What this trial is testing

Intranasal ChAdOx1 nCOV-19

Who this might be right for
Coronavirus
University of Oxford 42
Not applicableUnknownNCT04900467
What this trial is testing

Compare Immunological Efficacy of a Vaccine Regimen Combining Two Covid19 mRNA Vaccines (Pfizer-BioNTech and Moderna) With That of a Homologous Vaccination of Each Covid19 mRNA Vaccine

Who this might be right for
Adult Who Received a First Dose of an mRNA Vaccine (Pfizer-BioNTech or Moderna) and Need to Receive a Second Dose
Assistance Publique - Hôpitaux de Paris 418
Large-scale testing (Phase 3)UnknownNCT05636319
What this trial is testing

Evaluate the Efficacy, Safety, and Immunogenicity of SARS-CoV-2 Variant (BA.4 /5) mRNA Vaccine

Who this might be right for
COVID-19
Suzhou Abogen Biosciences Co., Ltd. 14,168
Next Page